AbCellera Biologics Inc. ABCL Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s total current liabilities?
- AbCellera Biologics Inc. (ABCL) reported total current liabilities of $47.29M in Q1 2026.
- How has AbCellera Biologics Inc.'s total current liabilities changed year-over-year?
- AbCellera Biologics Inc.'s total current liabilities decreased by 37.3% year-over-year, from $75.4M to $47.29M.
- What is the long-term trend for AbCellera Biologics Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s total current liabilities has grown at a -9.1% compound annual growth rate (CAGR), from $103.49M to $64.31M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.